Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel glucocorticoid agonists in early development at GSK

June 13, 2003

Life Medical Sciences cleared to begin pivotal trial of Repel-CV

June 12, 2003

ATL-1101 silences target gene in lab psoriasis studies

June 11, 2003

Biogen/Icos LFA-1 collaboration is concluded

June 11, 2003

Pivotal Actiza trial completes enrollment

June 10, 2003

Fujisawa and GSK sign U.S. copromotion agreement for Protopic

June 10, 2003

Piperine as a safe and effective treatment for vitiligo available from BTG

June 6, 2003

Noncalcemic vitamin D analogue for psoriasis, cancer, etc., discovered by WARF team

June 6, 2003

Enrollment completed in Atrisone phase III studies

June 5, 2003

Initial phase III results for canker sore treatment OraDisc A

May 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...